2-(4-(Benzyloxy)-2-ethyl-5-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

4-(5-Methyl-2-thienyl)-4-oxobutyric acid, 95.0%, 250mg

4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine, 95%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3,5-dimethylisoxazol-4-yl)phenyl)propanoic acid, 97%, 5g

(R)-2-((S)-2-CYCLOHEXYL-2-(PYRAZINE-2-CARBOXAMIDO)ACETAMIDO)-3,3-DIMETHYLBUTANOIC ACID, 97%, 100mg

GC capillary column ROTI®Cap-1, 25 m, 0.53 mm, 5.00 µm, 1 Piece(s)

2-Chloro-6-methoxy-4-(trifluoromethyl)nicotinonitrile, 97%, 5g

(3-Methoxy-4-nitrophenyl)methanol, 95.0%, 10g

2-(4-Methoxybenzyl)thiazole-4-carboxylic acid, 95+%, 1g

2,2'-Anhydro-1(B-D-arabinofuranosyl)uracil, 95.0%, 100g

7-Fluoroquinolin-8-ol, 95.0%, 1g

6-Fluoroflavone, 97.0%, 250mg

9-[2-(Diphenylphosphino)phenyl]-9H-carbazole, 97%, 5g